Market Research Reports

Aptamers Market (By Types - Nucleic Acid Aptamers and Peptide Aptamers; By Applications - Therapeutics Development, Diagnostics, Research and Development Applications and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

94pages
Published Date: 2014-06-18
 

Description


Aptamers are single standard oligonucleotides that exhibit high specificity and affinity to the variety of target molecules like proteins, bacteria or whole cell. Advancement in aptamer selection technologies which enables to generate high quality of aptamers coupled with efforts of key manufacturer to develop novel aptamers for diagnostics and therapeutics purpose will drive the market growth of global aptamers market. Aptamers technology also plays an important role in the field of biomarker discovery, drug development, analytical chemistry and others. The aptamers market is witnessing tremendous growth worldwide mainly due to various advantages over antibodies such as ease of synthesis and modification, ability to develop improved and cost-effective drugs. In addition, increasing number of scientific research on aptamers further propel the market growth. However, lack of knowledge coupled with ethical hurdles will restrain the market growth of global aptamers market. 

The market for aptamers is segmented into by types and by applications. Types segment includes nucleic aptamers and peptide aptamers. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019, considering 2012 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2013 to 2019 for each segment.

Aptamers market, by application segment divided into therapeutics development, diagnostics, research and development application and others. This report covers participation of different organizations of the U.S., the U.K. for the development of aptamer field. In addition, it explains various technological advancement and consistent efforts by key players to develop novel aptamers for therapeutic applications. The report includes market estimations of the global aptamers market in terms of value (USD million) for the period 2013 – 2019, considering 2012 as the base year. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global aptamers market. The report provides market size and forecasts for each segment and geographic region with CAGR % for the period from 2013 to 2019.

The market is also forecasted in terms of value (USD million) for the period 2013 – 2019 for four major geographic regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global aptamers market and future opportunities are provided in the aptamers market report. The market overview section of the report discusses the market dynamics that include drivers, restraints and opportunities influencing the market. In addition, major events have also been discussed in the section that have boosted the growth of the market and expected to further propel the growth during the forecast period. Also, this section covers market attractiveness analysis (by geography) for the year 2012 and Porter’s five forces analysis for the global aptamers market. Market share (%) by revenue for the major players operating in this market has also been provided for the year 2012 in the competitive landscape section, followed by a list of recommendations for the existing and new players. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company.

Some of the key market players of the global aptamers market include Aptagen, Inc., Aptamer group, Aptamer Sciences, Inc., Somalogic, Inc., NOXXAN Pharma AG and others. Market players are profiled in this report on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.

The global aptamers market is segmented into the following categories:
  • Aptamers Market, by Types
    • Nucleic Acid Aptamers
    • Peptide Aptamers
  • Aptamers Market, by Applications
    • Therapeutics Development
    • Diagnostics
    • Research and Development Application
    • Others
  • Aptamers Market, by Geography
    • North America
    • Europe
    • Asia-Pacific
    • Rest of World (RoW)

Table of Contents



Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
      1.3.1 Sources
               1.3.1.1 Secondary Research
               1.3.1.2 Primary Research
               1.3.1.3 Assumptions
1.4 List of Abbreviations

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Aptamers Market (2012 & 2019)
      2.1.1 Global Aptamers Market by Types, 2012 (USD Million)
2.2 Comparative Analysis: Global Aptamers Market, By Geography, 2012 and 2019 (Value %)

Chapter 3 Market Overview
3.1 Overview
3.2 Event Impact Analysis
3.3 Market Dynamics
      3.3.1 Market Drivers
               3.3.1.1 Increasing interest of research scientists in the field of aptamer technology owing to various advantages over antibodies
               3.3.1.2 Rising support and participation of private organizations aiming to increase advancements in aptamer field
      3.3.2 Market Restraints
               3.3.2.1 Inadequate regulatory policies and ethical issues related to aptamer development
               3.3.2.2 Lack of knowledge and unfavorable characteristics of aptamers will lead low acceptance
      3.3.3 Market Opportunities
               3.3.3.1 Modification in aptamer chemistry will offer high acceptance
3.4 Porter’s Five Force Analysis
      3.4.1 Bargaining power of suppliers – Low - Medium
      3.4.2 Bargaining power of buyers – Low - Medium
      3.4.3 Threat of substitutes – High – Medium
      3.4.4 Threat of new entrants – Medium - High
      3.4.5 Competitive rivalry – Low - Medium
3.5 Market Attractiveness Analysis: Global Aptamers Market, by Geography

Chapter 4 Aptamers Market, by Types
4.1 Introduction
      4.1.1 Global Aptamers Market Revenue, by Types, 2011 – 2019 (USD Million)
4.2 Nucleic Acid Aptamers
      4.2.1 Global Nucleic Acid Aptamers Market Revenue, 2011 – 2019 (USD Million)
4.3 Peptide Aptamers
      4.3.1 Global Peptide Aptamers Market Revenue, 2011 – 2019 (USD Million)

Chapter 5 Aptamers Market, by Applications
5.1 Overview
      5.1.1 Global Aptamers Market Revenue, by Applications, 2011 – 2019 (USD Million)
5.2 Therapeutics Development
      5.2.1 Global Therapeutics Development Application Market Revenue, 2011 – 2019 (USD Million)
5.3 Diagnostics (Molecular Imaging, Biomarker Detection and Discovery)
      5.3.1 Global Diagnostics Application Market Revenue, 2011 – 2019 (USD Million)
5.4 Research and Development Applications (Targeted Drug Delivery, Drug Discovery and Development)
      5.4.1 Global Research and Development Application Market Revenue, 2011 – 2019 (USD Million)
5.5 Others (Biosensor and Food Safety)
      5.5.1 Global Others Application Market Revenue, 2011 – 2019 (USD Million)

Chapter 6 Aptamers Market, by Geography
6.1 Overview
      6.1.1 Global Aptamers Market Revenue, by Geography, 2011 – 2019 (USD Million)
6.2 North America
      6.2.1 North America Aptamers Market Revenue, 2011 – 2019 (USD Million)
6.3 Europe
      6.3.1 Europe Aptamers Market Revenue, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
      6.4.1 Asia-Pacific Aptamers Market Revenue, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
      6.5.1 RoW Aptamers Market Revenue, 2011 – 2019 (USD Million)

Chapter 7 Competitive Landscape
7.1 Market Share by Key Players of Global Aptamers Market, 2012 (%)
      7.1.1 Global Aptamers Market Share Analysis, by Key Players, 2012 (%)

Chapter 8 Recommendations
8.1 Market Strategy for Success
      8.1.1 Focus on emerging aptamer selection technologies that improves aptamer affinity and specificity
      8.1.2 Focus on investing in research and development activities

Chapter 9 Company Profiles
9.1 AM Biotechnologies, LLC
      9.1.1 Company Overview
      9.1.2 Financial Overview
      9.1.3 Product Portfolio
      9.1.4 Business Strategies
      9.1.5 Recent Developments
9.2 Aptagen, LLC
      9.2.1 Company Overview
      9.2.2 Financial Overview
      9.2.3 Product Portfolio
      9.2.4 Business Strategies
      9.2.5 Recent Developments
9.3 Aptamer group
      9.3.1 Company Overview
      9.3.2 Financial Overview
      9.3.3 Product Portfolio
      9.3.4 Business Strategies 
      9.3.5 Recent Developments
9.4 Aptamer Sciences, Inc.
      9.4.1 Company Overview
      9.4.2 Financial Overview
      9.4.3 Product Portfolio
      9.4.4 Business Strategies 
      9.4.5 Recent Developments
9.5 Base Pair Biotechnologies, Inc.
      9.5.1 Company Overview
      9.5.2 Financial Overview
      9.5.3 Product Portfolio
      9.5.4 Business Strategies 
      9.5.5 Recent Developments
9.6 Bioapter S.L.
      9.6.1 Company Overview
      9.6.2 Financial Overview
      9.6.3 Product Portfolio
      9.6.4 Business Strategies 
9.7 CD Genomics
      9.7.1 Company Overviews
      9.7.2 Financial Overview
      9.7.3 Product Portfolio
      9.7.4 Business Strategies 
9.8 Neo Ventures Biotechnology, Inc.
      9.8.1 Company Overview
      9.8.2 Financial Overview
      9.8.3 Product Portfolio
      9.8.4 Business Strategies 
      9.8.5 Recent Developments
9.9 NOXXON Pharma AG
      9.9.1 Company Overview
      9.9.2 Financial Overview
      9.9.3 Product Portfolio
      9.9.4 Business Strategies 
      9.9.5 Recent Developments
9.10 Optech Biotech
      9.10.1 Company Overview
      9.10.2 Financial Overview
      9.10.3 Product Portfolio
      9.10.4 Business Strategies 
      9.10.5 Recent Developments
9.11 Ophthotech Corporation
      9.11.1 Company Overview
      9.11.2 Product Portfolio
      9.11.3 Business Strategies 
9.12 Regado Biosciences, Inc.
      9.12.1 Company Overview
      9.12.2 Financial Overview
      9.12.3 Product Portfolio
      9.12.4 Business Strategies 
      9.12.5 Recent Developments
9.13 Somalogic, Inc.
      9.13.1 Company Overview
      9.13.2 Financial Overview
      9.13.3 Product Portfolio
      9.13.4 Business Strategies 
      9.13.5 Recent Developments
9.14 TriLink Biotechnologies, Inc.
      9.14.1 Company Overview
      9.14.2 Financial Overview
      9.14.3 Product Portfolio
      9.14.4 Business Strategies 
      9.14.5 Recent Developments
9.15 Vivonics, Inc.
      9.15.1 Company Overview
      9.15.2 Financial Overview
      9.15.3 Product Portfolio
      9.15.4 Business Strategies
      9.15.5 Recent Developments

List of Figures

FIG. 1 Aptamers Market Segmentation
FIG. 2 Global Aptamers Market, by Types, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Aptamers Market, by Geography, 2012 and 2019 (Value %)
FIG. 4 Porter’s Five Forces Analysis: Global Aptamers Market
FIG. 5 Market Attractiveness Analysis: Global Aptamers Market, by Geography, 2012 Value (%)
FIG. 6 Global Nucleic Acid Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 7 Global Peptide Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 8 Global Therapeutics Development Application Market Revenue, 2011 – 2019 (USD Million)
FIG. 9 Global Diagnostics Application Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global Research and Development Application Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Others Application Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 North America Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Europe Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Asia-Pacific Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 RoW Aptamers Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global Aptamers Market: Market Share, by Key Players, 2012 (%)

List of Table

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Aptamers Market (2012 & 2019)
TABLE 3 Impact Analysis of Market Drivers
TABLE 4 Impact Analysis of Market Restraints
TABLE 5 Global Aptamers Market Revenue, by Types, 2011 – 2019 (USD Million)
TABLE 6 Global Aptamers Market Revenue, by Applications, 2011 – 2019 (USD Million)
TABLE 7 Global Aptamers Market Revenue, by Geography, 2011 – 2019 (USD Million)

Enquiry Before Buying


Free Market Analysis


Aptamers, also referred as chemical antibodies, are nucleic acid or peptide single-stranded oligonucleotides that bind strongly to target molecules. Aptamers contain unique secondary and tertiary structures that provide high specificity to a variety of target molecules ranging from nano-molar to whole protein molecules. The aptamers market is witnessing rapid growth due to increasing efforts by key players to develop novel applications in the field of diagnostics, therapeutics and research applications using aptamer technology. Additionally, unique features of aptamers such as cost-effective development, high specificity and low immunogenic properties would attract researchers to increase investments in the aptamers market, thereby boosting market growth. However, ethical issues for the regulation of aptamer technology would hamper growth of the aptamers market. The global aptamers market was valued at USD 93.0 million in 2012. It is estimated to reach USD 4,333.0 million by 2019 at a CAGR of 73.1% from 2013 to 2019.

The aptamers market is segmented by types and by applications. The aptamers market, by types is divided into nucleic acid aptamers and peptide aptamers. Nucleic acid aptamers is expected to be the largest segment in the global aptamers market during the forecast period. Growth in this segment is attributed to increasing use of nucleic acid aptamers in diagnostic applications coupled with rising research and development activities. Additionally, the nucleic acid aptamers segment is projected to grow at the highest CAGR from 2013 to 2019. Wide application areas in the field of diagnostics and analytical chemistry coupled with several ongoing clinical trials to develop novel therapeutic nucleic acid aptamers would help this segment to grow consistently in future. 

The aptamers market, by application is segmented into therapeutics development, diagnostics, research and development applications and others. The diagnostics application segment accounted for the largest market share in 2012 due to availability of various diagnostic kits by key players for in vitro diagnostic purpose. However, the therapeutics application segment is estimated to grow at the highest CAGR due to increasing research and development activities in aptamer technology to develop novel therapeutic agents.

North America accounted for the largest share i.e., over 45% of the global aptamers market in 2012. The market in North America has been boosted by the presence of a large number of key players and increasing research and development activities by domiciled players. Europe accounted for the second largest share of the total market in 2012. The aptamers market is majorly driven by increasing use of aptamer technologies by small-scale industries in Europe. Asia Pacific is expected to be the fastest growing region due to increasing initiatives undertaken by governments for the development of aptamer technology coupled with huge growth opportunities.

The global aptamers market is dominated by a few key players including Aptagen, Inc., Aptamer Group, Base Pair Biotechnologies, Inc., Somalogic, Inc. and NOXXON Pharma AG.

aptamers-market
 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research